Ganeden Raises $12 Million

Ganeden Biotech, Inc., a Cleveland-based developer and marketer of OTC probiotic supplements that help maintain proper gastro-intestinal function and promote general immune health, has raised $12 million in its first round of institutional funding. Capital Resource Partners and DSM Venturing (the venture arm of Koninklijke DSM NV) co-led the deal. www.ganedenbiotech.com